Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition

被引:0
|
作者
Weronika Bielka
Agnieszka Przezak
Piotr Molęda
Ewa Pius-Sadowska
Bogusław Machaliński
机构
[1] Pomeranian Medical University,Department of Diabetology and Internal Diseases
[2] Pomeranian Medical University,Department of General Pathology
来源
Cardiovascular Diabetology | / 23卷
关键词
Diabetes; Type 1 diabetes; Type 2 diabetes; Double diabetes; Insulin resistance; Metabolic syndrome; Indirect insulin resistance markers;
D O I
暂无
中图分类号
学科分类号
摘要
Currently, the differentiation between type 1 diabetes (T1D) and type 2 diabetes (T2D) is not straightforward, and the features of both types of diabetes coexist in one subject. This situation triggered the need to discriminate so-called double diabetes (DD), hybrid diabetes or type 1.5 diabetes, which is generally described as the presence of the insulin resistance characteristic of metabolic syndrome in individuals diagnosed with T1D. DD not only raises the question of proper classification of diabetes but is also associated with a significantly greater risk of developing micro- and macroangiopathic complications, which was independent of glycaemic control. When considering the global obesity pandemic and increasing incidence of T1D, the prevalence of DD may also presumably increase. Therefore, it is of the highest priority to discover the mechanisms underlying the development of DD and to identify appropriate methods to prevent or treat DD. In this article, we describe how the definition of double diabetes has changed over the years and how it is currently defined. We discuss the accuracy of including metabolic syndrome in the DD definition. We also present possible hypotheses connecting insulin resistance with T1D and propose possible methods to identify individuals with double diabetes based on indirect insulin resistance markers, which are easily assessed in everyday clinical practice. Moreover, we discuss adjuvant therapy which may be considered in double diabetic patients.
引用
收藏
相关论文
共 50 条
  • [31] Neuronal elements in the pathogenesis of Type 1 diabetes
    Tsui, H
    Winer, S
    Jakowsky, G
    Dosch, HM
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2003, 4 (03): : 301 - 310
  • [32] No association of multiple type 2 diabetes loci with type 1 diabetes
    Raj, S. M.
    Howson, J. M. M.
    Walker, N. M.
    Cooper, J. D.
    Smyth, D. J.
    Field, S. F.
    Stevens, H. E.
    Todd, J. A.
    DIABETOLOGIA, 2009, 52 (10) : 2109 - 2116
  • [33] Innate immunity and the pathogenesis of type 1 diabetes
    Grieco, Fabio Arturo
    Vendrame, Francesco
    Spagnuolo, Isabella
    Dotta, Francesco
    SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (01) : 57 - 66
  • [34] Milk signalling in the pathogenesis of type 2 diabetes
    Melnik, B. C.
    CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION, 2011, : 17 - 22
  • [35] Role of pseudohypoxia in the pathogenesis of type 2 diabetes
    Song, Jing
    Yang, Xiaojuan
    Yan, Liang-Jun
    HYPOXIA, 2019, 7 : 33 - 40
  • [37] Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes
    Sridhar, Vikas S.
    Limonte, Christine P.
    Groop, Per-Henrik
    Heerspink, Hiddo J. L.
    Pratley, Richard E.
    Rossing, Peter
    Skyler, Jay S.
    Cherney, David Z. I.
    DIABETOLOGIA, 2024, 67 (01) : 3 - 18
  • [38] Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes
    Wen, Xianjie
    Yang, Yisheng
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2017, 58 (02) : R73 - R85
  • [39] Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes
    Hitt, Talia Alyssa Savic
    Katz, Lorraine E. Levitt
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2020, 49 (04) : 679 - +
  • [40] Symptomatic Type 1 Diabetes Is Approaching, but When?
    Toppari, Jorma
    Veijola, Riitta
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,